top of page
LA experiment.png

THE LOS ANGELES MEASLES VACCINE STUDY

Between 1990 and 1991, the Los Angeles study was conducted and followed 3 years after the Senegal study that examined the detrimental effects of the EZ-HT vaccine for measles in Africa. The goal of the experiment in Senegal was to study the clinical effectiveness of the new EZ-HT vaccine in young children. The study showed that the vaccine was dangerous; however, researchers were reluctant to quit the investigation, so they performed one last test to confirm the results. The CDC, as well as the World Health Organization, already knew about the lethality of the EZ-HT but considered the data to be “preliminary,” so the Los Angeles Study of 1990 was set in place. The study was conducted on infants, predominantly minorities, with the test pool being 88% children of color.

 

The CDC in order to target minorities would then claim that the Inglewood, East Los Angeles, and West Los Angeles regions (which had a higher populations of people of color) were being hit the hardest by measles however the Los Angeles County Department of Health actually showed that there were 14 other regions in L.A that were affected worse by the disease. In order to administer the tests, doctors informed parents that the Edmonton-Zagreb vaccine had been administered many times in Europe, and the consent forms given did not mention that the vaccine was experimental and was a much more potent version of the drug.

 

It wasn’t until 1991, when Dr. Joanne Hatim brought it up to the public, that the study was stopped but at that point, 1500 infants had already been tested on, the CDC claimed the kids suffered no side effects, but the children experienced what parents are describing as long-term immune system impairment, seizures and other acute conditions consistent with vaccine-induced injury. It was determined by Awadu that 1 in 13.3 kids would die if they were exposed to the vaccine,” and that the concentration within the experimental vaccine was 500 times greater than the normal pathogenic content. 

Sources:

Rohde, Wayne. “The Scandalous LA County Measles Vaccine Experiment: Is the Unsuspecting Public Still Being Used in Secret Vaccine Trials?” Vaccine Impact, 2 May 2017, vaccineimpact.com/2017/the-scandalous-la-county-measles-vaccine-experiment-is-the-unsuspecting-public-still-being-used-in-secret-vaccine-trials/.

Cimons, Marlene. “CDC Says It Erred in Measles Study.” Los Angeles Times, Los Angeles Times, 17 June 1996, www.latimes.com/archives/la-xpm-1996-06-17-mn-15871-story.html.

Peter Aaby, Badara Samb, Francois Simondon, Kim Knudsen, Awa Marie Coll Seck, John Bennett, Hilton Whittle, Divergent Mortality for Male and Female Recipients of Low-Titer and High-Titer Measles Vaccines in Rural Senegal, American Journal of Epidemiology, Volume 138, Issue 9, 1 November 1993, Pages 746–755, https://doi.org/10.1093/oxfordjournals.aje.a116912

bottom of page